USBC Inc (USBC): יחס חוב לטווח קצר להון עצמי

The USBC (USBC) price chart complements information regarding the development of innovative needle-free glucose monitoring systems, which are expected to generate stable future revenue through a subscription model. The brand enjoys high trust among patients seeking to replace painful pricks with laser technology. The current metric stands at 0.32, although market pricing is currently impossible due to the venture development stage and the absence of FDA approval.

This indicator assesses the extent of the company's reliance on long-term borrowings relative to its equity. By analyzing the dynamics of short-term liabilities to equity, an investor determines the efficiency of the financing structure and debt load risks. The metric is calculated as the ratio of liabilities with a maturity of more than one year to shareholders' equity. For USBC Inc (USBC), this is critical when organizing complex component logistics for the development of medical technologies.